Glenmark Life Sciences has reported results for fourth quarter (Q4) and year ended March 31, 2024.
The company has reported 33.08% fall in its net profit at Rs 97.94 crore for the quarter under review as compared to Rs 146.36 crore for the same quarter in the previous year. Total income of the company decreased by 13.53% at Rs 539.73 crore for Q4FY24 as compared Rs 624.16 crore for the corresponding quarter previous year.
For the year ended March 31, 2024, the company has reported marginal rise of 0.84% in its net profit at Rs 470.89 crore as compared to Rs 466.96 crore for the previous year. Total income of the company increased by 4.80% at Rs 2295.26 crore for year under review as compared to Rs 2190.18 crore for year ended March 31, 2023.
